HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Joe D Ensor Selected Research

Angiozyme

9/2012An open-label, phase 2 trial of RPI.4610 (Angiozyme) in the treatment of metastatic breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Joe D Ensor Research Topics

Disease

1Breast Neoplasms (Breast Cancer)
09/2012
1Disease Progression
09/2012

Drug/Important Bio-Agent (IBA)

1AngiozymeIBA
09/2012
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
09/2012

Therapy/Procedure

1Drug Therapy (Chemotherapy)
09/2012